The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
rac-4-(5-(4-Bromophenyl)-3-(2-oxo-4-phenyl-1,2-dihydroquinolin-3-yl)-4,5-dihydropyrazol-1-yl)-4-oxobutanoic Acid ID: ALA4475564
PubChem CID: 155537987
Max Phase: Preclinical
Molecular Formula: C28H22BrN3O4
Molecular Weight: 544.41
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CCC(=O)N1N=C(c2c(-c3ccccc3)c3ccccc3[nH]c2=O)CC1c1ccc(Br)cc1
Standard InChI: InChI=1S/C28H22BrN3O4/c29-19-12-10-17(11-13-19)23-16-22(31-32(23)24(33)14-15-25(34)35)27-26(18-6-2-1-3-7-18)20-8-4-5-9-21(20)30-28(27)36/h1-13,23H,14-16H2,(H,30,36)(H,34,35)
Standard InChI Key: KBWNABXQYOAIMF-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
10.7342 -12.0927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7331 -12.9209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4450 -13.3320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4432 -11.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1599 -12.0890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1587 -12.9184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8729 -13.3296 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5929 -12.9204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5940 -12.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8753 -11.6711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8758 -10.8494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5931 -10.4391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5935 -9.6141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8772 -9.1983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1591 -9.6177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1623 -10.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3087 -11.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0627 -12.0169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6140 -11.4035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2048 -10.6867 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3966 -10.8557 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3074 -13.3331 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5408 -9.9327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3623 -9.8487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0593 -9.2627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4377 -11.3997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8529 -12.1140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6758 -12.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0831 -11.3941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6657 -10.6799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8441 -10.6869 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6987 -9.0990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5160 -9.0155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8524 -8.2658 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9972 -9.6816 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.9047 -11.3892 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
10 11 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 2 0
9 17 1 0
8 22 2 0
20 23 1 0
23 24 1 0
23 25 2 0
19 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
24 32 1 0
32 33 1 0
33 34 2 0
33 35 1 0
29 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 544.41Molecular Weight (Monoisotopic): 543.0794AlogP: 5.50#Rotatable Bonds: 6Polar Surface Area: 102.83Molecular Species: ACIDHBA: 4HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 3.85CX Basic pKa: ┄CX LogP: 4.91CX LogD: 1.67Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: -0.67
References 1. Bagnolini G, Milano D, Manerba M, Schipani F, Ortega JA, Gioia D, Falchi F, Balboni A, Farabegoli F, De Franco F, Robertson J, Pellicciari R, Pallavicini I, Peri S, Minucci S, Girotto S, Di Stefano G, Roberti M, Cavalli A.. (2020) Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib., 63 (5): [PMID:32037829 ] [10.1021/acs.jmedchem.9b01526 ]